Literature DB >> 24709377

[Preliminary analysis of the relationship between peripheral arterial disease and other atherosclerosis markers and diabetic nephropathy].

José Rioja1, Tamara Moreno2, Inmaculada Coca3, Manuel Jiménez-Villodres4, Alejandro Rodríguez-Morata5, Pedro Valdivielso2.   

Abstract

OBJECTIVES: To determine lipid serum levels, lipoproteins and other markers related to nephropathy and peripheral arterial disease (PAD) in a type 2 diabetes population stratified according to their level of renal dysfunction.
METHODS: A cross-sectional study was conducted on 72 type 2 diabetic patients followed-up in outpatient clinics. Patients were divided into 4 groups according to their estimated glomerular filtration rate (eGFR, mL/min) and albumin/creatinine ratio (ACR, mg/g) (eGFR > 60 and ACR < 30 [n = 23], eGFR > 60 and ACR > 30 [n = 12], eGFR30-60 [n = 23] and eGFR < 30 [n = 14]). Clinical and anthropometric characteristic of all patients were recorded. Fasting lipids and apolipoproteins, as well as renal and hematology parameters were measured. Finally, a multivariate Wald stepwise logistic regression statistic analysis was performed to determine variables independently associated with the presence of renal dysfunction.
RESULTS: The univariate statistical analysis showed that the higher renal dysfunction, the higher the prevalence of hypertension, smoking habit and triglycerides levels, and the lower hemoglobin levels (P < .05). The multivariate statistical analysis showed that only triglycerides levels (OR: 1.019, 95% CI: 1.004-1.034) and hemoglobin levels (OR: 0.516 95% CI: 0.292-0.914) were independently associated to the presence of renal dysfunction (eGFR < 60 mL/min.). The further inclusion of the presence of PAD in the statistical model did not modify those associations.
CONCLUSION: The results confirm the relationship between triglycerides levels and diabetic nephropathy, independently of the presence of PAD.
Copyright © 2013 Sociedad Española de Arteriosclerosis. Published by Elsevier España. All rights reserved.

Entities:  

Keywords:  Diabetic nephropathy; Enfermedad arterial periférica; Nefropatía diabética; Peripheral arterial disease; Triglicéridos; Triglycerides

Mesh:

Substances:

Year:  2014        PMID: 24709377     DOI: 10.1016/j.arteri.2014.02.004

Source DB:  PubMed          Journal:  Clin Investig Arterioscler        ISSN: 0214-9168


  2 in total

1.  Tetrandrine down-regulates expression of miRNA-155 to inhibit signal-induced NF-κB activation in a rat model of diabetes mellitus.

Authors:  Chunhui Song; Yunxi Ji; Guohui Zou; Chunxia Wan
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Evaluation of Metabolic Syndrome and Its Associated Risk Factors in Type 2 Diabetes: A Descriptive Cross-Sectional Study at the Komfo Anokye Teaching Hospital, Kumasi, Ghana.

Authors:  Francis Agyemang-Yeboah; Benjamin Ackon Jnr Eghan; Max Efui Annani-Akollor; Eliezer Togbe; Sampson Donkor; Bright Oppong Afranie
Journal:  Biomed Res Int       Date:  2019-05-02       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.